Symbiotec Pharmalab IPO, which was oversubscribed 73.63 times by non-institutional investors, will list on 1 September. The grey market premium is currently +203, indicating a potential listing price above the IPO price of ₹988.
Symbiotec Pharmalab IPO, which was oversubscribed 73.63 times by non-institutional investors, will list on 1 September. The grey market premium is currently +203, indicating a potential listing price above the IPO price of ₹988.
<iframe src="https://hindustansphere.com/embed/cluster/0f33bc36b87a83d7953fcbffcd503aad8be20142" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Symbiotec Pharmalab IPO listing tomorrow: Here’s what GMP hints ahead of debut"></iframe>
